Pulse Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $18.6M | $54.2M | $28.6M |
| FY2022 | $80.1M | $77.9M | $61.1M |
| FY2023 | $14.8M | $59.2M | $44.4M |
| FY2024 | $17.6M | $132.5M | $118.0M |
| FY2025 | $13.9M | $94.5M | $80.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $18.6M | $54.2M | $28.6M |
| FY2022 | $80.1M | $77.9M | $61.1M |
| FY2023 | $14.8M | $59.2M | $44.4M |
| FY2024 | $17.6M | $132.5M | $118.0M |
| FY2025 | $13.9M | $94.5M | $80.7M |